BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11026745)

  • 1. Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on performance on two operant timing schedules.
    Chiang TJ; Al-Ruwaitea AS; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2000 Sep; 151(4):379-91. PubMed ID: 11026745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of d-amphetamine on performance on two operant timing schedules.
    Chiang TJ; Al-Ruwaitea AS; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2000 Jun; 150(2):170-84. PubMed ID: 10907670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S; Chiang TJ; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2001 Nov; 158(3):305-13. PubMed ID: 11713621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats.
    Body S; Kheramin S; Mobini S; Ho MY; Velazquez-Martinez DN; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2002 Dec; 13(8):603-14. PubMed ID: 12478210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 8-OH-DPAT on temporal discrimination following central 5-hydroxytryptamine depletion.
    Body S; Chiang TJ; Mobini S; Ho MY; Bradshaw CM; Szabadi E
    Pharmacol Biochem Behav; 2002 Apr; 71(4):787-93. PubMed ID: 11888569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z; Rickard JF; Body S; Asgari K; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors.
    Body S; Kheramin S; Ho MY; Miranda Herrera F; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2004 Nov; 176(2):154-65. PubMed ID: 15103450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of repeated treatment with 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) on the lever press responding of the rat under FI and DRL schedules of food reinforcement.
    Evenden J; Ryan C; Palejko W
    Psychopharmacology (Berl); 1995 Jul; 120(1):81-92. PubMed ID: 7480539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM; Chang YH
    Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):223-32. PubMed ID: 11699570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 8-OH-DPAT and WAY-100635 on performance on a time-constrained progressive-ratio schedule.
    Ho MY; Body S; Kheramin S; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2003 May; 167(2):137-44. PubMed ID: 12655461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of a (+)amphetamine discriminative stimulus in rats by 8-hydroxy-2-(N,N-di-n-propylamino)tetralin (8-OH DPAT).
    Young R; Bondareva T; Wesolowska A; Glennon RA
    Pharmacol Biochem Behav; 2006 Apr; 83(4):612-7. PubMed ID: 16675002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of dorsal or median raphe injections of 8-OH-DPAT in three operant tasks measuring response inhibition.
    Fletcher PJ
    Behav Brain Res; 1993 Apr; 54(2):187-97. PubMed ID: 8323715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M; Samanin R
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H; Velázquez-Martínez DN
    J Psychopharmacol; 2001 Mar; 15(1):29-36. PubMed ID: 11277605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the 5-HT(1A) agonist (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on cocaine choice in cynomolgus monkeys.
    Czoty PW; McCabe C; Nader MA
    Behav Pharmacol; 2005 May; 16(3):187-91. PubMed ID: 15864074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 5-HT1A and 5-HT2A receptor stimulation on temporal differentiation performance in the fixed-interval peak procedure.
    Asgari K; Body S; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Behav Processes; 2006 Feb; 71(2-3):250-7. PubMed ID: 16098683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation.
    Fletcher PJ; Tampakeras M; Yeomans JS
    Pharmacol Biochem Behav; 1995 Sep; 52(1):65-71. PubMed ID: 7501680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.